Literature DB >> 6701328

Portal venous system measurements in portal hypertension.

M Lafortune, D Marleau, G Breton, A Viallet, P Lavoie, P M Huet.   

Abstract

The diameters of the portal, splenic, superior mesenteric, and coronary veins were measured during umbilicoportal venography in 64 cirrhotic patients with or without portal hypertension. The diameter of the portal vein did not increase along with the portohepatic gradient and even tended to decrease depending on the severity of hypertension and the opening of spontaneous portosystemic shunts. While there was no relationship between portohepatic gradient and splenic or superior mesenteric vein diameter, a coronary vein larger than 0.7 cm was associated with a portohepatic gradient greater than 10 mm Hg. This could be a useful sign of severe portal hypertension.

Entities:  

Mesh:

Year:  1984        PMID: 6701328     DOI: 10.1148/radiology.151.1.6701328

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  14 in total

1.  Comparison between ultrasonographic signs and the degree of portal hypertension in patients with cirrhosis.

Authors:  V Vilgrain; D Lebrec; Y Menu; A Scherrer; H Nahum
Journal:  Gastrointest Radiol       Date:  1990

2.  Intravascular volume in cirrhosis. Reassessment using improved methodology.

Authors:  W G Rector; F Ibarra
Journal:  Dig Dis Sci       Date:  1988-04       Impact factor: 3.199

3.  Sonographic evaluation of the portal venous system after elective endoscopic sclerotherapy of esophageal varices.

Authors:  G C Caletti; E Brocchi; L Zani; L Bolondi; M Baraldini; V Rollo; L Barbara
Journal:  Surg Endosc       Date:  1987       Impact factor: 4.584

4.  Normal portal venous diameter in children.

Authors:  H B Patriquin; G Perreault; A Grignon; J Boisvert; D Filiatrault; L Garel; H Blanchard
Journal:  Pediatr Radiol       Date:  1990

5.  Chronic liver disease: noninvasive subharmonic aided pressure estimation of hepatic venous pressure gradient.

Authors:  John R Eisenbrey; Jaydev K Dave; Valgerdur G Halldorsdottir; Daniel A Merton; Cynthia Miller; José M Gonzalez; Priscilla Machado; Suhyun Park; Scott Dianis; Carl L Chalek; Christopher E Kim; Jeffrey P Baliff; Kai E Thomenius; Daniel B Brown; Victor Navarro; Flemming Forsberg
Journal:  Radiology       Date:  2013-03-22       Impact factor: 11.105

6.  On the implementation of an automated acoustic output optimization algorithm for subharmonic aided pressure estimation.

Authors:  J K Dave; V G Halldorsdottir; J R Eisenbrey; D A Merton; J B Liu; P Machado; H Zhao; S Park; S Dianis; C L Chalek; K E Thomenius; D B Brown; F Forsberg
Journal:  Ultrasonics       Date:  2013-01-02       Impact factor: 2.890

7.  Investigating the efficacy of subharmonic aided pressure estimation for portal vein pressures and portal hypertension monitoring.

Authors:  Jaydev K Dave; Valgerdur G Halldorsdottir; John R Eisenbrey; Daniel A Merton; Ji-Bin Liu; Jian-Hua Zhou; Hsin-Kai Wang; Suhyun Park; Scott Dianis; Carl L Chalek; Feng Lin; Kai E Thomenius; Daniel B Brown; Flemming Forsberg
Journal:  Ultrasound Med Biol       Date:  2012-08-21       Impact factor: 2.998

8.  Clinically severe portal hypertension: role of multi-detector row CT features in diagnosis.

Authors:  Ji Young Lee; Tae Yeob Kim; Woo Kyoung Jeong; Yongsoo Kim; Jinoo Kim; Kyoung Won Kim; Young Hwan Kim; Joo Hyun Sohn
Journal:  Dig Dis Sci       Date:  2014-04-11       Impact factor: 3.199

9.  The diameter of the originating vein determines esophageal and gastric fundic varices in portal hypertension secondary to posthepatitic cirrhosis.

Authors:  Hai-ying Zhou; Tian-wu Chen; Xiao-ming Zhang; Li-ying Wang; Li Zhou; Guo-li Dong; Nan-lin Zeng; Hang Li; Xiao-li Chen; Rui Li
Journal:  Clinics (Sao Paulo)       Date:  2012       Impact factor: 2.365

10.  Doppler surrogate endoscopy for screening esophageal varices in patients with cirrhosis.

Authors:  Kambiz Akhavan Rezayat; Fariborz Mansour Ghanaei; Ahmad Alizadeh; Afshin Shafaghi; Ali Babaei Jandaghi
Journal:  Hepat Mon       Date:  2014-01-16       Impact factor: 0.660

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.